WTW:NASDAQWillis Towers Watson Public Limited Company Analysis
Data as of 2026-03-10 - not real-time
$291.83
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Willis Towers Watson is trading at $291.83, comfortably above its 20‑day, 50‑day and 200‑day moving averages, signaling a short‑term bearish technical stance. However, the stock posted a Q4 EPS of $8.12, beating consensus estimates, and analysts maintain a "Buy" rating with a median target of $370, implying roughly 27% upside. The RSI sits near 40, hinting at modest downside risk, while the MACD histogram turned positive, offering a hint of bullish momentum. Fundamentally, the company delivers a solid 20% ROE, a low payout ratio of 22%, and a dividend yield of 1.3%, which appears sustainable given its strong operating cash flow. Valuation metrics are mixed: the trailing P/E of 17.9 is slightly above the industry average, yet the forward P/E of 13 suggests earnings acceleration, and the DCF fair value of $238 marks the current price as potentially overvalued. High 30‑day volatility (≈50%) and a decreasing volume trend raise short‑term risk, but the low beta (~0.35) dampens market‑wide swings. Overall, the stock balances growth drivers from earnings beats and a strong dividend with technical weakness and valuation concerns, positioning it for a cautious but optimistic outlook.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price below key moving averages indicating bearish technical bias
- Earnings beat and strong cash flow support near‑term stability
- High short‑term volatility and declining volume
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Analyst median target of $370 suggests ~27% upside
- Forward P/E compression indicating earnings acceleration
- Sustainable dividend and low payout ratio
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Consistently high ROE and solid operating margins
- Diversified advisory and broking franchise with resilient cash generation
- Dividend yield and low payout ratio provide income stability
Key Metrics & Analysis
Financial Health
Revenue Growth-3.30%
Profit Margin16.53%
P/E Ratio17.9
ROE20.08%
ROA4.83%
Debt/Equity85.75
P/B Ratio3.5
Op. Cash Flow$1.8B
Free Cash Flow$1.9B
Industry P/E17.4
Technical Analysis
TrendBearish
RSI40.1
Support$275.60
Resistance$310.02
MA 20$296.78
MA 50$314.21
MA 200$319.95
MACDBullish
VolumeDecreasing
Fear & Greed Index80.86
Valuation
Fair Value$238.05
Target Price$369.42
Upside/Downside26.59%
GradeOvervalued
TypeBlend
Dividend Yield1.30%
Risk Assessment
Beta0.35
Volatility50.03%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.